JP2003512328A - レボシメンダンの新規用途 - Google Patents

レボシメンダンの新規用途

Info

Publication number
JP2003512328A
JP2003512328A JP2001531390A JP2001531390A JP2003512328A JP 2003512328 A JP2003512328 A JP 2003512328A JP 2001531390 A JP2001531390 A JP 2001531390A JP 2001531390 A JP2001531390 A JP 2001531390A JP 2003512328 A JP2003512328 A JP 2003512328A
Authority
JP
Japan
Prior art keywords
levosimendan
sinus
syndrome
node
sinoatrial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001531390A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003512328A5 (https=
Inventor
レヒトネン、ラッセ
ルダ、ミクハイル
ホウゼンプッド、ジェフリー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2003512328A publication Critical patent/JP2003512328A/ja
Publication of JP2003512328A5 publication Critical patent/JP2003512328A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP2001531390A 1999-10-22 2000-10-20 レボシメンダンの新規用途 Pending JP2003512328A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI19992298 1999-10-22
FI992298 1999-10-22
PCT/FI2000/000915 WO2001028560A1 (en) 1999-10-22 2000-10-20 A new use of levosimendan

Publications (2)

Publication Number Publication Date
JP2003512328A true JP2003512328A (ja) 2003-04-02
JP2003512328A5 JP2003512328A5 (https=) 2011-06-23

Family

ID=8555494

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001531390A Pending JP2003512328A (ja) 1999-10-22 2000-10-20 レボシメンダンの新規用途

Country Status (9)

Country Link
US (1) US6911209B1 (https=)
EP (1) EP1248620B1 (https=)
JP (1) JP2003512328A (https=)
AT (1) ATE282414T1 (https=)
AU (1) AU7928700A (https=)
CA (1) CA2387920C (https=)
DE (1) DE60016038T2 (https=)
ES (1) ES2231277T3 (https=)
WO (1) WO2001028560A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132275B2 (en) 2010-11-18 2015-09-15 Cardiac Pacemakers, Inc. Automatic determination of chronotropic incompetence using atrial pacing at rest
WO2021126884A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HF-pEF)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01113317A (ja) * 1987-09-28 1989-05-02 Smith Kline Ltd 抗不整脈剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5969017A (en) * 1996-10-31 1999-10-19 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01113317A (ja) * 1987-09-28 1989-05-02 Smith Kline Ltd 抗不整脈剤

Also Published As

Publication number Publication date
EP1248620B1 (en) 2004-11-17
AU7928700A (en) 2001-04-30
ATE282414T1 (de) 2004-12-15
CA2387920C (en) 2008-08-26
CA2387920A1 (en) 2001-04-26
WO2001028560A1 (en) 2001-04-26
DE60016038D1 (de) 2004-12-23
EP1248620A1 (en) 2002-10-16
ES2231277T3 (es) 2005-05-16
DE60016038T2 (de) 2005-12-22
US6911209B1 (en) 2005-06-28

Similar Documents

Publication Publication Date Title
KR101653071B1 (ko) 선별적 ｓ1ｐ₁ 수용체 작동약에 대한 투약 섭생
EP2300001A1 (en) Dronedarone for the prevention of permanent atrial fibrillation
JP2002540144A (ja) 心血管及び関連病理学治療のためのピリドキシン化合物の使用
JPH07501547A (ja) 光学的に純粋な（−）アムロジピンを用いる，高血圧，狭心症および他の疾患を治療するための方法および組成物
Waagstein et al. Clinical results with prenalterol in patients with heart failure
JP2003512328A (ja) レボシメンダンの新規用途
CA2335280C (en) Method of treating pulmonary hypertension
JP2003512328A5 (https=)
EP0968715B1 (en) Loratadine for use as an antiarrhymthmic
JP4628622B2 (ja) 冠状動脈移植片血管攣縮の治療または予防方法
HUP0201650A2 (hu) Amino-tetralin-származékok alkalmazása szív- és érrendszeri betegségek gyógykezelésére használható gyógyszerek előállítására
US7485642B2 (en) Method for treating septic shock
JP3931218B2 (ja) 拡張不全型心不全予防薬
JPH07501551A (ja) 光学的に純粋なｓ（−）フェロジピンを用いる，高血圧，狭心症および他の疾患を治療するための方法および組成物
WO2007023775A1 (ja) 心房細動治療剤
JPH08268891A (ja) 徐脈性不整脈治療剤
JPH0196133A (ja) 脳循環改善剤
JPWO2001058488A1 (ja) シェーグレン症候群の治療剤
JP2001521898A (ja) 心筋虚血およびアンギナの処置のためのキナプリルの使用
JPS63145231A (ja) ステロイド化合物を含有する脳機能賦活剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070913

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20100527

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110201

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20110428

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110621